Fingerprint
Dive into the research topics of 'Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw
Tomoko Higuchi, Yoshihiko Soga, Misato Muro, Makoto Kajizono, Yoshihisa Kitamura, Toshiaki Sendo, Akira Sasaki
Research output: Contribution to journal › Article › peer-review
20
Citations
(Scopus)